Innovator behind Tylenol dies
This article was originally published in The Tan Sheet
Executive SummaryRobert L. McNeil Jr., the grandson of the founder of McNeil Laboratories and the driving force behind the launch of the first widely marketed non-aspirin OTC pain reliever, dies at age 94. McNeil, who remained with McNeil Laboratories when Johnson & Johnson acquired it in 1959 before retiring in 1964, died of heart failure on May 20 at his home in Wyndmoor, Pa. In 1936, he joined the firm his grandfather started in 1897, according to an obituary published by Kirk and Nice Funeral Homes. McNeil spearheaded the development of Butisol drugs, led the team that created Tylenol and named the active ingredient acetaminophen. Tylenol remains an iconic OTC brand
You may also be interested in...
Having had a very fruitful year in terms of regulatory approvals, the Swiss major will reveal how successful its new products have been commercially. Of particular interest will be the performance of eye drug Beovu as it takes on Bayer's rival Eylea.
Executives On The Move: New Picks For Finance Posts At Cambrex And Editas Medicine, And Zimmer Biomet Fills Communications Spot
Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.